RT Journal Article
SR Electronic
T1 Mobile outreach testing for COVID-19 in twenty homeless shelters in Toronto, Canada
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.23.20235465
DO 10.1101/2020.11.23.20235465
A1 Kiran, Tara
A1 Craig-Neil, Amy
A1 Das, Paul
A1 Lockwood, Joel
A1 Wang, Ri
A1 Nathanielsz, Nikki
A1 Rosenthal, Esther
A1 Snider, Carolyn
A1 Hwang, Stephen W.
YR 2020
UL http://medrxiv.org/content/early/2020/11/24/2020.11.23.20235465.abstract
AB Background It is unclear what the best strategy is for detecting COVID-19 among homeless shelter residents and what individual factors are associated with positivity.Methods We conducted a retrospective chart audit obtaining repeated cross-sectional data from outreach testing done at homeless shelters between April 1st and July 31st, 2020 in Toronto, Canada. We compared the positivity rate for shelters tested because of an outbreak (at least one known case) versus surveillance (no known cases). A patient-level analysis examined differences in demographic, health, and behavioural characteristics of residents who did and did not test positive for COVID-19.Findings One thousand nasopharyngeal swabs were done on 872 unique residents at 20 shelter locations. Among the 504 tests done in outbreak settings, 69 (14%) were positive and 1 (0.2%) was indeterminate. Among the 496 tests done for surveillance, 11 (2%) were positive and none were indeterminate. Shelter residents who tested positive were significantly less likely to have a health insurance card (54% vs 72%, p=0.03) or have visited another shelter in the last 14 days (0% vs 18%, p<0.01) compared to those who tested negative; There was no association between COVID-19 positivity and medical history (p=0.40) or symptoms (p=0.43).Interpretation Our findings support testing of asymptomatic shelter residents for COVID-19 when a positive case is identified at the same shelter but suggest limited utility of testing all shelter residents in the absence of a known case. Visiting another shelter in the last 14 days is associated with a decreased risk of COVID-19 positivity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a grant from the St. Michael's Hospital Foundation. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. Dr. Kiran is the Fidani Chair in Improvement and Innovation at the University of Toronto. She is supported as a Clinician Scientist by the Department of Family and Community Medicine at the University of Toronto and at St. Michael's Hospital. She is also supported by the Canadian Institutes of Health Research and Health Quality Ontario as an Embedded Clinician Researcher. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Unity Health TorontoAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.